Immunotope Inc is categorized under Commercial Biotechnical Research in Doylestown, PA and active since 2003.
Immunotope Inc was established in 2003, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.
If you are seeking more information, feel free to contact Ramila Philip at the company’s single location by writing to 3805 Old Easton Road, Doylestown, Pennsylvania PA 18902 or by phoning (215) 489-4945. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Immunotope Inc |
| Contact Person: | Ramila Philip |
| Address: | 3805 Old Easton Road, Doylestown, Pennsylvania 18902 |
| Phone Number: | (215) 489-4945 |
| Website Address: | immunotope.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2003 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Biotechnical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541711 |
| Share This Business: |
Immunotope Inc was started in 2003 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Ramila Philip for inquiries that concern Immunotope Inc by calling the company number (215) 489-4945, as your correspondence is most welcome. Additionally, the physical location of the single location of Immunotope Inc can be found at the coordinates 40.333189,-75.12617 as well as the street address 3805 Old Easton Road in Doylestown, Pennsylvania 18902.
For its online presence, you may visit Immunotope Inc’s website at immunotope.com and engage with its social media outlets through on Twitter and on Facebook.